House Committee Adds $5.9 Mil. To FDA Budget For Drug Safety, Ad Review
This article was originally published in The Pink Sheet Daily
Executive Summary
The Appropriations Committee unanimously endorses a managers’ amendment that would provide FDA with an additional $5 mil. for “highest priority drug safety needs” and $884,000 for ad review division staff in fiscal year 2006.